177 related articles for article (PubMed ID: 33289466)
1. State of Artemisinin and Partner Drug Susceptibility in
Montenegro LM; de Las Salas B; Neal AT; Tobon-Castaño A; Fairhurst RM; Lopera-Mesa TM
Am J Trop Med Hyg; 2021 Jan; 104(1):263-270. PubMed ID: 33289466
[TBL] [Abstract][Full Text] [Related]
2. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
3.
Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
[TBL] [Abstract][Full Text] [Related]
4. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
[TBL] [Abstract][Full Text] [Related]
5. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
Phyo AP; Ashley EA; Anderson TJC; Bozdech Z; Carrara VI; Sriprawat K; Nair S; White MM; Dziekan J; Ling C; Proux S; Konghahong K; Jeeyapant A; Woodrow CJ; Imwong M; McGready R; Lwin KM; Day NPJ; White NJ; Nosten F
Clin Infect Dis; 2016 Sep; 63(6):784-791. PubMed ID: 27313266
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
[TBL] [Abstract][Full Text] [Related]
9. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
[TBL] [Abstract][Full Text] [Related]
10. K13 propeller domain mutations and pfmdr1 amplification in isolates of Plasmodium falciparum collected from Thai-Myanmar border area in 2006-2010.
Phompradit P; Chaijaroenkul W; Muhamad P; Na-Bangchang K
Folia Parasitol (Praha); 2019 May; 66():. PubMed ID: 31239407
[TBL] [Abstract][Full Text] [Related]
11. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
12. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
[TBL] [Abstract][Full Text] [Related]
13. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.
Bwire GM; Ngasala B; Mikomangwa WP; Kilonzi M; Kamuhabwa AAR
Sci Rep; 2020 Feb; 10(1):3500. PubMed ID: 32103124
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
17. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.
Chhibber-Goel J; Sharma A
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():49-58. PubMed ID: 31606696
[TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
[TBL] [Abstract][Full Text] [Related]
19. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
[TBL] [Abstract][Full Text] [Related]
20. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
